Singleton reactors in the diagnosis of swine vesicular disease: The role of coxsackievirus B5

Veterinary Microbiology

Volumn 76, Issue 3, 2000, Pages 291-297

  Moonen, P ^a   Van Poelwijk, F ^a   Moormann, R ^a   Dekker, A ^a  

^a WAGENINGEN UNIVERSITY   (Netherlands)

Author keywords

Coxsackie virus B5; Picornaviridae; Swine vesicular disease virus

Indexed keywords

ANTIBODY TITER; ANTIGEN DETECTION; ARTICLE; COXSACKIE VIRUS B; CROSS REACTION; NONHUMAN; SERODIAGNOSIS; SWINE DISEASE; VIRUS INFECTIVITY; VIRUS NEUTRALIZATION;

ANIMALS; ENTEROVIRUS B, HUMAN; IMMUNOSORBENT TECHNIQUES; MALE; SWINE; SWINE VESICULAR DISEASE; VACCINATION;

ANIMALIA; COXSACKIEVIRUS; PICORNAVIRIDAE; RNA VIRUSES; SUS SCROFA; SWINE VESICULAR DISEASE VIRUS;

EID: 0034308020     PISSN: 03781135     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0378-1135(00)00239-X     Document Type: Article

References (14)

1. Brocchi E., Zhang G., Knowles N.J., Wilsden G., McCauley J.W., Marquardt O., Ohlinger V.F., De Simone F. Molecular epidemiology of recent outbreaks of swine vesicular disease: two genetically and antigenically distinct variants in Europe, 1987-1994. Epidemiol. Infect. 118:1997;51-61.
2. Brown F., Wild T.F., Rowe L.W., Underwood B.O., Harris T.J.R. Comparison of swine vesicular disease virus and coxsackie B5 virus by serological and RNA hybridisation methods. J. Gen. Virol. 31:1976;231-237.
3. Chenard G., Bloemraad M., Kramps J.A., Terpstra C., Dekker A. Validation of a monoclonal antibody based ELISA to detect antibodies directed against swine vesicular disease virus. J. Virol. Methods. 75:1998;105-112.
4. Clarke, G.M., 1980. Statistics and Experimental Design. In: Willis, A.J., Sleigh M.A. (Eds.), Contemporary Biology, Arnold, London, New York, Melbourne, Auckland, pp. 81-88.
5. De Castro M.P. Behaviour of the foot-and-mouth disease virus in cell cultures: susceptibility of the IBRS-2 line. Archivos do Instituto Biologico São Paulo. 31:1964;63-78.
6. Dekker, A., 2000. Pathogenesis, diagnosis and epizootiology of swine vesicular disease. Thesis, University Utrecht, 30 March 2000.
7. Dekker A., Terpstra C. Aspects of the epidemiology of swine vesicular disease. Collection of samples as part of herd surveillance. Tijdschr. Diergeneeskd. 121:1996;347-349.
8. Dekker A., Moonen P.L.J.M., Terpstra C. Validation of a screening liquid phase blocking ELISA for swine vesicular disease. J. Virol. Methods. 51:1995;343-348.
9. Golding S.M., Hedger R.S., Talbot P. Radial immuno-diffusion and serum-neutralisation techniques for the assay of antibodies to swine vesicular disease. Res. Vet. Sci. 20:1976;142-144.
10. Graves J.H. Serological relationship of swine vesicular disease virus and coxsackie B5 virus. Nature. 245:1973;314.
11. Hulst M.M., Westra D.F., Wensvoort G., Moormann R.J.M. Glycoprotein E1 of hog cholera virus expressed in insect cells protects swine from hog cholera. J. Virol. 67:1993;5435-5442.
12. Lai S.S., McKercher P.D., Moore D.M., Gillespie J.H. Response of pigs to recent isolates of coxsackievirus B5. Comp. Immunol. Microbiol. Infect. Dis. 2:1980;459-468.
13. Nardelli L., Lodetti E., Gualandi G.L., Burrows R., Goodridge D., Brown F., Cartwright B. A foot-and-mouth disease syndrome in pigs caused by an enterovirus. Nature. 219:1968;1275-1276.
14. Zhang G., Wilsden G., Knowles N.J., McCauley J.W. Complete nucleotide sequence of a coxsackie B5 virus and its relationship to swine vesicular disease virus. J. Gen. Virol. 74:1993;845-953.